MRI Safe Implantable Defibrillator Devices Market Size, Share, and Trends 2025 to 2034

MRI Safe Implantable Defibrillator Devices Market (By Product Type: Single-Chamber ICDs, Dual-Chamber ICDs, Biventricular/CRT-D ICDs, Subcutaneous ICDs (S-ICD), Others; By Battery Technology: Lithium-Ion, Lithium Silver Vanadium Oxide, Others; By End-User/Treatment Setting: Hospitals/Cardiac Centers, Ambulatory Surgical Centers, Specialty Clinics, Other) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : 24 Nov 2025  |  Report Code : 7131  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MRI Safe Implantable Defibrillator Devices Market 

5.1. COVID-19 Landscape: MRI Safe Implantable Defibrillator Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porters Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MRI Safe Implantable Defibrillator Devices Market, By Product Type

8.1. MRI Safe Implantable Defibrillator Devices Market Revenue and Volume, by Product Type

8.1.1 Single-Chamber ICDs

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Dual-Chamber ICDs

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Biventricular/CRT-D ICDs

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Subcutaneous ICDs (S-ICD)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others (specialty/pediatric ICDs)

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global MRI Safe Implantable Defibrillator Devices Market, By Battery Technology

9.1. MRI Safe Implantable Defibrillator Devices Market Revenue and Volume, by Battery Technology

9.1.1. Lithium-Ion

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Lithium Silver Vanadium Oxide

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global MRI Safe Implantable Defibrillator Devices Market, By End-User/Treatment Setting

10.1. MRI Safe Implantable Defibrillator Devices Market Revenue and Volume, by End-User/Treatment Setting

10.1.1. Hospitals/Cardiac Centers

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Specialty Clinics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Other

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global MRI Safe Implantable Defibrillator Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Battery Technology

11.1.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.1.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.1.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Battery Technology

11.2.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.2.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.2.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Battery Technology

11.2.6.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Battery Technology

11.2.7.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Battery Technology

11.3.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.3.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.3.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Battery Technology

11.3.6.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Battery Technology

11.3.7.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.4.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.4.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Battery Technology

11.4.6.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Battery Technology

11.4.7.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Battery Technology

11.5.4.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Battery Technology

11.5.5.3. Market Revenue and Volume Forecast, by End-User/Treatment Setting

Chapter 12. Company Profiles

12.1. Medtronic plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott Laboratories

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Boston Scientific Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Biotronik SE & Co. KG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LivaNova PLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ZOLL Medical Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. MicroPort Scientific Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Philips Healthcare

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Nihon Kohden Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. St. Jude Medical

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The MRI safe implantable defibrillator devices market size is expected to increase from USD 1,750 million in 2025 to USD 3,400 million by 2034.

The MRI safe implantable defibrillator devices market is expected to grow at a compound annual growth rate (CAGR) of around 7.64% from 2025 to 2034.

The major players in the MRI safe implantable defibrillator devices market include St. Jude Medical, Nihon Kohden Corporation, Philips Healthcare, MicroPort Scientific Corporation, ZOLL Medical Corporation, LivaNova PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, and Abbott Laboratories.

The driving factors of the MRI safe implantable defibrillator devices market are the rising cardiac disorders, increasing MRI procedures, and technological advancements in safer, more efficient implantable devices.

North America region will lead the global MRI safe implantable defibrillator devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client